Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
This research study is evaluating the combination of olaparib and temozolomide as a possible treatment for Small Cell Lung Cancer.
Phase I/II Study of Olaparib and Temozolomide in Patients with Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- ClinicalTrials.gov Identifier: NCT02446704
- Protocol Number: 15-121
- Principal Investigator: Deepa Rangachari
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required